Survival of patients with advanced and recurrent ovarian cancer treated using integrative medicine in Malaysia: A case series.

CONCLUSION: These findings suggest that CAM may be a valuable addition to conventional therapy to treat and improve the survival of patients with ovarian cancers. A formal randomized control trial is required to evaluate the efficacy and long-term outcomes of using IM to treat advanced and recurrent ovarian cancers. PMID: 31521007 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31521007?dopt=Abstract

Source: Complementary Therapies in Clinical Practice - September 5, 2019 Category: Complementary Medicine Authors: Linus-Lojikip S, Subramaniam V, Lim WY, Hss AS Tags: Complement Ther Clin Pract Source Type: research